Background Antiretroviral preexposure prophylaxis has been shown to reduce the risk of
human immunodeficiency virus type 1 (HIV-1) infection in some studies, but conflicting results …

Importance Severe pneumonia with hyperinflammation and elevated interleukin-6 is a common
presentation of coronavirus disease 2019 (COVID-19). Objective To determine whether …

Background The level of evidence for HIV transmission risk through condomless sex in
serodifferent gay couples with the HIV-positive partner taking virally suppressive antiretroviral …

Background Data for on-demand pre-exposure prophylaxis (PrEP) are scarce. We implemented
a cohort study to assess its efficacy, safety, and effect on sexual behaviour. Methods We …

Background Patients with COVID-19 pneumonia have an excess of inflammation and
increased concentrations of cytokines including interleukin-1 (IL-1). We aimed to determine …

Background. The pilot phase IIb VIKING study suggested that dolutegravir (DTG), a human
immunodeficiency virus (HIV) integrase inhibitor (INI), would be efficacious in INI-resistant …

Background Nivolumab was associated with higher rates of objective response than chemotherapy
in a phase 3 study involving patients with ipilimumab-refractory metastatic melanoma…

Background Increased rates of sexually transmitted infections (STIs) have been reported
among men who have sex with men. We aimed to assess whether post-exposure prophylaxis (…

Purpose Mucosal melanoma is an aggressive malignancy with a poor response to conventional
therapies. The efficacy and safety of nivolumab (a programmed death-1 checkpoint …

The double-blind phase of the randomized ANRS IPERGAY trial, evaluating sexual activity-based
oral HIV pre-exposure prophylaxis (PrEP), was conducted among high-risk men who …